• [stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

    Ten Experts On A NIH COVID-19 Panel Have Ties To Companies Involved In Coronavirus treatment

    August 12, 2020
    No Comments
    Ten Experts On A NIH COVID-19 Panel Have Ties To Companies Involved In Coronavirus treatment
    Screenshot

    Members of the National Institutes of Health's COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.

    According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 "intended for healthcare providers."

    A total of eight panel members list a financial relationship with Gilead Sciences on the panel's Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD...

    To read more visit Just The News.

    SHARE THIS ARTICLE

    Author

    CDM Staff

    The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."
  • Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments

    FOLLOW US

  • Subscribe to our evening newsletter to stay informed during these challenging times!!

    ×